Rifaximin Does Not Increase the Rate of 30-Day Mortality in Patients with Cirrhosis and Daptomycin in Two National US-based Cohorts
Gastroenterology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined